Dr. Thomas Kahan is professor of medicine at Karolinska Institutet, Stockholm. He is a senior consultant in cardiology at Danderyd University Hospital with focus on coronary artery disease, heart failure and vascular medicine, was head of the Cardiovascular Risk Assessment Unit, a European Society of Hypertension Excellence Centre from 1989, and was responsible for cardiovascular research from 2005.
Dr. Kahan is past chair person of the ESC Council of Hypertension, and past president of the International Society of Cardiovascular Pharmacotherapy.
His main research interests are neurohormonal mechanisms in the control of blood pressure and cardiac function, with focus on structural myocardial and vascular changes, vascular function, and neuroendocrine mechanisms in hypertension and heart failure. Other areas of interest are risk assessment and prevention, health economics, and implementation of treatment. Dr. Kahan’s research has published approximately 320 scientific papers.
